GENE ONLINE|News &
Opinion
Blog

2025-11-29|

Ethical Challenges Highlighted in AI Integration Within Pharmacy Practice

by GOAI
Share To

A recent analysis highlights the importance of addressing ethical considerations in the use of artificial intelligence (AI) within pharmacy practice. The report examines how AI technologies are increasingly integrated into healthcare systems, particularly in pharmacies, and emphasizes the need for careful evaluation of their impact on patient care, privacy, and professional responsibilities. Key areas of concern include data security, algorithmic bias, transparency in decision-making processes, and maintaining human oversight.

The findings detail several challenges associated with AI implementation in pharmacy settings. One major issue involves ensuring that algorithms used to assist pharmacists do not perpetuate biases or inaccuracies that could affect patient outcomes. Another concern is safeguarding sensitive patient information as AI systems process large volumes of data to provide recommendations or streamline operations. Additionally, experts stress the importance of transparency in how AI-driven decisions are made and advocate for maintaining human involvement to ensure ethical standards are upheld. The report calls for ongoing discussions among healthcare professionals, policymakers, and technologists to address these issues as AI continues to evolve within the field.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 29, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top